Hong Kong Genome Institute 香港基因組中心

The Government announced the appointments to the Board of Directors of the Hong Kong Genome Institute (HKGI) today (November 13). 
 
The Secretary for Health has reappointed Mr Philip Tsai Wing-chung and Professor Raymond Liang Hin-suen as the Chairperson, with a tenure ending on July 26, 2027, and the Deputy Chairperson, with a tenure ending on July 26, 2028, of the HKGI respectively.

In addition, six non-official Directors have been reappointed, and seven non-official Directors, namely Professor Philip Chiu Wai-yan, Professor Joshua Ho Wing-kei, Ms Fran Hung Suk-fan, Mr Terry Lai Ka-wai, Professor Li King-chuen, Dr Alastair Mah Pui-yan and Ms Alice Yip Ka-ming, have been newly appointed.  The tenure of all non-official Directors will end on November 4, 2028.  

The HKGI is a private company limited by guarantee and wholly owned by the Government, and is responsible for implementing the Hong Kong Genome Project (HKGP). With the support of the Health Bureau, the HKGI has been committed to fostering the development of genomic medicine in Hong Kong, and has been working closely with the Department of Health, the Hospital Authority, the medical schools of local universities and other stakeholders to accelerate the integration of genomic medicine into clinical applications, advance scientific research, nurture talent and enhance public genomic literacy.

The Secretary for Health, Professor Lo Chung-mau, said, "I am pleased to note that the HKGP achieved its first-phase target of recruiting 50 000 participants ahead of schedule last year. Through analysing the whole genome sequencing results, clinicians can make more precise diagnoses, thereby providing participants with more appropriate treatment and preventive options. The HKGP also facilitates the establishment of a database that combines genetic and clinical information, helping clinicians and researchers understand the causes of different diseases and driving the development of more effective screening, diagnostic and treatment methods.

"I believe that, under the sterling leadership of Mr Tsai and Professor Liang, together with the staunch support of the new Board of Directors, the HKGI will build on its achievements and foster the steady development of genomic medicine, benefitting more members of the public and contributing to Hong Kong's development into an international health and medical innovation hub."
 
Professor Lo expressed his heartfelt gratitude to the retired members, namely Mr Ray Chan, Ms Ivy Cheung Wing-han, Dr Shawn Leung Shui-on, Dr Isabella Liu, Professor Dennis Lo Yuk-ming, Mr Tim Pang Hung-cheong, Professor Ian Wong Chi-kei, Dr Michael Wong Lap-gate, and Professor Yiu Siu-ming, for their unfailing support for, and invaluable contributions to, the work of the HKGI during their tenure.

The latest membership of the Board of Directors of the HKGI is as follows:
 
Chairperson:
Mr Philip Tsai Wing-chung
 
Deputy Chairperson:
Professor Raymond Liang Hin-suen
 
Non-official Directors:
Professor Allen Chan Kwan-chee  
Professor Herbert Chia Pun-kok  
Professor Philip Chiu Wai-yan  
Professor Joshua Ho Wing-kei  
Ms Fran Hung Suk-fan  
Mr Terry Lai Ka-wai  
Professor Wallace Lau Chak-sing  
Professor Li King-chuen  
Dr Alastair Mah Pui-yan  
Mr Stephen Wong Kai-yi  
Professor Wong Yung-hou  
Ms Alice Yip Ka-ming  
Professor Yip Shea-ping  
Chief Executive Officer, Hong Kong Genome Institute
 
Official Directors:
Under Secretary for Health  
Deputy Secretary for Health  
Deputy Director of Health